GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, ESR1, F10, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, KDR, MAOA, MET, POLA1, POLB, PPARA, SRC, TNKS, TNKS2, XDH |
11.4954 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
11.0019 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, PTGES, TBXAS1 |
10.8263 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, HTR5A, IGF1R, POLB, PPARA, PTGES, SRC, TYR |
10.3529 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR5A, IGF1R, KDR, POLB, PPARA, PTGES, SRC, TYR |
9.76106 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, POLB, PPARA, PTGES, SRC, TOP1, TYR |
9.49644 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, HTR5A, PTGES, SRC, TYR |
9.26396 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FLT3, HSD11B2, HTR5A, PTGES, SRC, TYR |
9.24752 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, TYR |
9.22795 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HSD11B2, HTR2A, HTR2B, KDR, POLB, SRC, TOP1 |
9.20573 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
8.14021 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FUT7, GBA2, HTR2B, PIM1, PPARA, PTGES, TBXAS1, TYR, XDH |
7.8144 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, CNR1, CNR2, DRD2 |
7.60759 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CDK6, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC, TNKS, TNKS2 |
7.60759 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
7.55415 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
7.52673 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, GBA2, HTR1A, MAOA, TYR |
7.44779 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A |
7.2271 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.11889 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, PIM1, PTGES, SRC, XDH |
6.97081 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.78913 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.78913 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.78913 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MAOA, MET, PIM1, POLA1, POLB, PPARA, PTGES, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
6.78913 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, POLB, SRC |
6.74573 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
6.70901 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CHRM2, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
6.70901 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, MAOA, TYR |
6.57234 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, MET, POLA1, POLB, SRC |
6.43078 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MAOA, TBXAS1, TYR, XDH |
6.42586 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES, TBXAS1 |
6.24846 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, HTR2A |
6.21465 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, HTR2A |
6.21465 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, POLA1, POLB, PPARA, PTGES, PTPN1, SRC, TOP1, TYR |
6.19615 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MET, PIM1, PPARA, SRC, TNKS2, TOP1, TYR |
6.11965 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, PIM1, POLB, PPARA, SIGMAR1, SRC, TNKS2, TYR |
6.1044 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MAOA, MET, PIM1, POLA1, POLB, PPARA, PTGES, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
6.00183 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD2, FABP3, FABP4, FUT7, GBA2, MET, PPARA, PTGES, TBXAS1 |
5.9919 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.94671 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, PPARA, SRC |
5.94215 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES, TBXAS1 |
5.93893 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CYP1B1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, XDH |
5.92829 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, IGF1R, PPARA, SRC |
5.88352 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.85152 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
5.84236 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
5.84236 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES, TBXAS1 |
5.73711 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
5.71204 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
5.71198 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.66536 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.63314 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AXL, BCL2, CA1, CA2, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PIM1, POLB, PPARA, PTGES, PTPN1, SIGMAR1, SRC, TNKS, TNKS2 |
5.58612 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, MAOA |
5.48253 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, POLB, PPARA, SRC, TYR |
5.39614 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM2, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
5.36986 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, PTGES, SRC |
5.25887 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HTR5A, KDR, PIM1, POLB, PPARA, SIGMAR1, SRC, TYR |
5.23697 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.15606 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
5.11672 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A, MAOA |
5.09622 |
[BP] GO:0007200 |
None
|
ADRA1A, CHRM2, DRD1, DRD2, ESR1, HTR2A, HTR2B |
4.99461 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PTPN1, SRC, XDH |
4.98415 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, APP, CA2, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
4.8624 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, ESR1, FABP4, IGF1R, MET, PIM1, PPARA, PTPN1, SRC, TNKS |
4.83225 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, DRD3, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
4.78629 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC, TNKS, TOP1 |
4.76145 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.76145 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, SRC, TNKS, TNKS2 |
4.75663 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B, MET |
4.71886 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES, TBXAS1 |
4.62453 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, ESR1, HTR7, PPARA, SRC, TOP1 |
4.54922 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, PTGES, TBXAS1 |
4.5291 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
4.5291 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1, DRD2, HTR2A |
4.47512 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, PPARA, PTGES, TBXAS1 |
4.40557 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.38993 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.38993 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, DRD2, DRD3, TNKS, TNKS2 |
4.38993 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HSD11B2, HTR2A, HTR2B, POLB, PPARA, SRC, TYR |
4.38993 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DRD3, ESR1, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, PIM1 |
4.38892 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, IGF1R, KDR, MET, SRC |
4.35298 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MAOA, MET, PIM1, POLA1, POLB, PPARA, PTGES, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
4.27874 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PTGES, PTPN1, SRC, TNKS, TNKS2, XDH |
4.1762 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2 |
4.1225 |
[BP] GO:0051952 |
None
|
ADORA1, CNR1, DRD1, DRD2, DRD3, HTR2A |
4.08 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.06179 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.06179 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, SRC |
4.06179 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
4.04052 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.02755 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, DRD2, DRD3, PPARA |
4.02755 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
4.01798 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.98777 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.98777 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.98777 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SIGMAR1, SRC, XDH |
3.96834 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
3.91129 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, POLB, PTPN1, SRC, TNKS, TOP1, XDH |
3.90569 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
3.89522 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PTPN1, SIGMAR1, SRC, XDH |
3.86156 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AXL, BCL2, CA2, CA7, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, PTPN1, SRC |
3.86089 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.84311 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 |
3.83195 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
3.81616 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.79082 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DRD1, DRD2, DRD3, FABP3, FLT3, HSD11B2, IGF1R, PPARA, SRC, TYR |
3.76985 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
3.76714 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, DRD3, HTR2A, MET |
3.74682 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
3.74522 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, DRD3, FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC |
3.72722 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, SRC |
3.71224 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, SRC |
3.69583 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC, TNKS, TOP1 |
3.67316 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F10, F3, MET, SRC, XDH |
3.66772 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, HTR2A, HTR2B |
3.66159 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HTR1A, HTR2B, IGF1R, KDR, MAOA, MET, PIM1, POLB, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TYR, XDH |
3.66159 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, CNR1, DRD2, DRD3, HSD11B2, PPARA |
3.62379 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, POLB, PTPN1, SRC, TNKS, TOP1, XDH |
3.62379 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.6041 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A6, CYP2D6 |
3.6041 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A6, CYP2D6 |
3.6041 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2, HSD11B2 |
3.6041 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2B, IGF1R, KDR, MET, PIM1, POLA1, POLB, PPARA, PTGES, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
3.6041 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.57787 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, GBA2, PPARA, PTGES, TBXAS1 |
3.54763 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DRD1, DRD2, DRD3, FABP3, FLT3, HSD11B2, IGF1R, PPARA, SRC, TYR |
3.44704 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2, DRD3 |
3.44453 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.42768 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.42768 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD1, DRD2, HTR2A |
3.41136 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, PIM1, PTPN1, SIGMAR1, SRC, XDH |
3.39786 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC, TNKS, XDH |
3.39137 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
3.36746 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, PIM1, PPARA, PTPN1, SRC, TNKS, XDH |
3.35861 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, MAOA |
3.34111 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, DRD3, HTR2A |
3.34111 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
3.33233 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
3.33233 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, DRD2, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
3.32531 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, APP, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, DRD3, HSD11B2, HTR1A, HTR2A, HTR2B, HTR7, SRC, TYR |
3.30772 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.29398 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.24288 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, BCL2, CYP19A1, ESR1 |
3.23922 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2D6, CYP3A4, MAOA |
3.23896 |
[BP] GO:0045777 |
None
|
ADORA1, ADRA1A, CNR1, HSD11B2 |
3.18693 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.18693 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, DRD3, TNKS2 |
3.18343 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
3.16892 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.16304 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.1595 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PPARA, PTPN1, SRC, XDH |
3.13374 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PTGES, PTPN1, SRC, TNKS, TNKS2, XDH |
3.10019 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, MET, PIM1, POLA1, SRC, TYR |
3.10019 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
3.09846 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.09616 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PPARA, PTPN1, SRC, XDH |
3.0918 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC |
3.07771 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.05369 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGES |
3.04898 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.04543 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
3.04543 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, KDR, MET, PPARA |
3.04287 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
3.00759 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, KDR, PTPN1, SRC |
2.96997 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.96997 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.96354 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.96329 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.96329 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, KDR, SRC |
2.96329 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.9597 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, BCL2, CDK6, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, PPARA, PTPN1, SRC, XDH |
2.9597 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MET, PIM1, POLA1, POLB, PPARA, PTGES, PTPN1, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
2.95273 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, SRC |
2.95273 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
2.95169 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
2.95169 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.93586 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PPARA, PTPN1, SRC, XDH |
2.90338 |
[BP] GO:0014075 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.89613 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.89197 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.87695 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.86348 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.86348 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.86348 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SRC |
2.86348 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, GBA2, MAOA, SRC, XDH |
2.86294 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.849 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, POLB, PPARA, SRC |
2.83572 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PPARA |
2.82672 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.82541 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, CNR1, DRD2, DRD3, HTR2A |
2.81426 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.80087 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.79966 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, SRC |
2.79438 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.78777 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, DRD2, FLT3, HTR2A, HTR2B, IGF1R, KDR, PTPN1, SRC, XDH |
2.78777 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.78762 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.78762 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.78762 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MET, PIM1, POLA1, POLB, PPARA, PTGES, PTPN1, SIGMAR1, SRC, TNKS, TNKS2, TOP1, XDH |
2.78734 |
[BP] GO:0099536 |
None
|
CHRM2, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.77611 |
[BP] GO:0099537 |
None
|
CHRM2, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.77611 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ADRA1A, ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, DRD3, HSD11B2, HTR2A, PTGES, SRC, TYR |
2.77347 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.77261 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, GBA2, MAOA, XDH |
2.768 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PTPN1, SRC, TNKS, TNKS2, XDH |
2.76591 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR2A |
2.75686 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.7358 |
[BP] GO:0042391 |
None
|
ADORA1, ADRA1A, APP, BCL2, CNR1, CNR2, DRD1, KDR, SRC |
2.72028 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD2, ESRRB, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
2.7194 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, GBA2, PIM1, PPARA, PTGES, TBXAS1, TYR |
2.71639 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.71272 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AXL, BCL2, CHRM2, CNR1, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
2.67177 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MET, PIM1, PTPN1, SRC |
2.67177 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.67177 |
[BP] GO:0097366 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.67177 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, BCL2, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, PTPN1, SRC, XDH |
2.67177 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CHRM2, CNR1, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
2.66089 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, BCL2, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, PTPN1, SRC, XDH |
2.65989 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.65126 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, ESR1, IGF1R, MET, PTPN1, SRC, XDH |
2.6451 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.6451 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.6451 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.6451 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, F10, FLT3, IGF1R, KDR, MET, SRC, TNKS, TOP1 |
2.64197 |
[BP] GO:0007568 |
aging
|
ADRA1A, AURKB, BCL2, CNR1, CYP1A1, HTR2A, POLB |
2.62823 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, PTGES |
2.61712 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, DRD3, HTR2A |
2.61552 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.60415 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.6031 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR |
2.58803 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.58484 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.57518 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.55201 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.5206 |
[BP] GO:0007610 |
None
|
APP, BCL2, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, PPARA |
2.51322 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.51322 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, SRC, TNKS, TOP1 |
2.51322 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.51322 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.51322 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.51322 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.51322 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.51322 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.51322 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.51322 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, SRC, TNKS, TNKS2 |
2.50228 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.49293 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, POLA1 |
2.48437 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.45173 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.45173 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, SRC |
2.45125 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, APP, AXL, BCL2, CA2, CDK6, CHRM2, CNR1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, HTR2A, HTR2B, KDR, MET, PIM1, SRC, TNKS2, XDH |
2.44909 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.44846 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.44846 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, CYP2D6, MET, PPARA, SRC, TNKS |
2.43802 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, SRC |
2.40775 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A, MAOA |
2.40359 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.39568 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.39535 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, TOP1 |
2.39535 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MET, POLB, PTPN1, SRC |
2.39033 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.3894 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, SRC |
2.38354 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, PPARA, SRC |
2.37539 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, APP, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, DRD3, ESRRB, F3, HTR2A, HTR2B, KDR, MET, PIM1, SRC |
2.37453 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PTPN1, SRC, XDH |
2.37453 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
2.37205 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FABP4, GBA2, MAOA, SRC, XDH |
2.37015 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, GBA2, PIM1, PPARA, PTGES, TBXAS1, TYR |
2.36529 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, SRC |
2.36326 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, PPARA |
2.36326 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.3517 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.33714 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AOX1, APP, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2B, MAOA, POLA1, POLB, PPARA, TOP1, TYR, XDH |
2.32618 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CHRM2, CNR1, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
2.32437 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, PPARA, SRC |
2.31011 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DRD1, SRC, TNKS, TOP1 |
2.30655 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.30655 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.30655 |
[BP] GO:0070988 |
demethylation
|
CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
2.30655 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
2.30655 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, GBA2, PIM1, PPARA, PTGES, TBXAS1, TYR |
2.30655 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, APP, BCL2, CDK6, CYP1B1, DRD2, FABP3, PTGES, XDH |
2.30655 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.30517 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, POLA1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, XDH |
2.30448 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, SRC |
2.29196 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.29196 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.2863 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.28414 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.28414 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.28414 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.28414 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CNR1, DRD1, DRD2, DRD3, HTR2A |
2.28369 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.26668 |
[BP] GO:0051953 |
None
|
ADORA1, CNR1, DRD2 |
2.26668 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.26668 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26668 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, PTPN1, SRC, TNKS, XDH |
2.26668 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, MET, PTPN1, SRC, TNKS, XDH |
2.25733 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.24906 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD1, DRD2, DRD3, PPARA |
2.22531 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.21838 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, PIM1, PTPN1, SRC |
2.21799 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.21799 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21799 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, SRC |
2.20523 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, DRD1, KDR, SRC |
2.20523 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.20523 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.20523 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, DRD2, DRD3, TYR |
2.17806 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, MET, PPARA, SRC, TNKS, TNKS2 |
2.16074 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA |
2.15514 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CDK6, CNR1, CNR2, CYP19A1, DRD2, ESR1, F3, FABP4, IGF1R, MET, PPARA, PTPN1, SRC, XDH |
2.14053 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.1353 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC, TNKS |
2.13129 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.12712 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.12712 |
[BP] GO:0007268 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.12492 |
[BP] GO:0098916 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.12492 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, PPARA, SRC |
2.11784 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.11784 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, PPARA, SRC |
2.11194 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.11194 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.11194 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.11194 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.11194 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.11194 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.11194 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.11194 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.11194 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.11194 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, CNR1, DRD2, DRD3, ESR1, IGF1R, KDR, MET, SRC, TNKS, TNKS2 |
2.10597 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.0963 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, SRC |
2.08777 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.08576 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3 |
2.06288 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.05345 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.05345 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3 |
2.04241 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.02733 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, HTR7, PPARA, TOP1 |
2.02101 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA4, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
7.17046 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX5, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MET, PIM1, PTGES, PTPN1, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TYR |
6.21465 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MET, PTGES, PTPN1, SIGMAR1, SRC, TBXAS1, TYR |
5.85152 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
5.59924 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, F10, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGES, PTPN1, SIGMAR1, TBXAS1 |
4.8556 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA2, CA4, CA9, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SRC |
4.24797 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGES, SIGMAR1, TBXAS1 |
4.18334 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, CA12, CA14, CA4, CA9, CHRM2, CNR1, CNR2, CYP3A4, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MET, PTGES, SIGMAR1, TBXAS1, TYR |
3.73116 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2A, HTR5A, KDR, MAOA, PIM1, POLA1, PTGES, PTPN1, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
3.57606 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, GBA2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PIM1, PTPN1, SRC |
3.533 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.42768 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, CA12, CA14, CA9, CHRM2, CNR1, CNR2, CYP3A4, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MET, PTGES, SIGMAR1, TBXAS1, TYR |
2.82532 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MET, PIM1, POLA1, POLB, PPARA, PTGES, PTPN1, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
2.66093 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.39568 |
[CC] GO:0005783 |
None
|
ADORA1, APP, BCL2, CA4, CYP19A1, CYP2D6, FLT3, GBA2, HTR5A, KDR, PTPN1, SIGMAR1, XDH |
2.389 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, CA2, CDK6, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, HTR6, SRC |
2.36326 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, CHRM2, CNR1, DRD1, DRD2, HTR2A, MET, SIGMAR1, SRC |
2.26668 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, CA2, CDK6, CHRM2, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, SRC |
2.13637 |
[CC] GO:0031090 |
None
|
ADRA1A, ALOX5, APP, BCL2, CA4, CHRM2, CNR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, FUT7, GBA2, MAOA, SIGMAR1, SRC, TNKS, TNKS2, TYR |
2.03521 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TYR, XDH |
11.0019 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, PIM1, POLA1, POLB, PPARA, PTGES, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
10.732 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.76106 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1 |
9.07135 |
[MF] GO:0008227 |
None
|
ADRA1A, CHRM2, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
8.86203 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CDK6, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1 |
8.39114 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4 |
8.12548 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1 |
7.97533 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.97533 |
[MF] GO:0030594 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.86632 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, PIM1, POLA1, POLB, PPARA, PTPN1, TBXAS1, TNKS, TNKS2, TYR, XDH |
7.63227 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, TBXAS1, XDH |
7.60759 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MAOA, TBXAS1, TYR, XDH |
7.60759 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, F10, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, PIM1, POLA1, POLB, PTGES, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
7.60759 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1 |
7.2271 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, SIGMAR1, SRC, TOP1 |
7.17046 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, TBXAS1, TYR |
7.17046 |
[MF] GO:0099528 |
None
|
CHRM2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.17046 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
6.83651 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.78913 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.78913 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.78913 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.78913 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, HSD11B2, HSD17B1, POLA1, PTGES, SRC, TBXAS1, XDH |
6.72397 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
6.70313 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
6.35627 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
6.35627 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, SRC, TBXAS1 |
6.23311 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.21465 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, SRC, TBXAS1 |
6.00183 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, TBXAS1, TYR |
5.64516 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
5.31599 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
5.02524 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
4.96841 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
4.92053 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
4.45666 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A6, CYP2D6, CYP3A4 |
4.43329 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
4.03344 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.74522 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.74522 |
[MF] GO:0008289 |
lipid binding
|
AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA |
3.62062 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, PIM1, POLA1, POLB, PPARA, PTPN1, TBXAS1, TNKS, TNKS2, TYR, XDH |
3.42048 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.41136 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.39526 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.32683 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.29398 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.29398 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.14607 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.95169 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, PPARA, PTPN1, TNKS |
2.91105 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.89776 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.87695 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.87695 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.86348 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, PIM1, POLA1, POLB, PPARA, PTPN1, SRC, TBXAS1, TOP1, XDH |
2.85468 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.70458 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
2.5206 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.51322 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.51322 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.39568 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.3894 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.33905 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.28414 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.28414 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.28414 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, POLA1, POLB, SRC, TOP1 |
2.14392 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.11194 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.11194 |